The role of bisphosphonates in multiple myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2009, v. 4, n. 2, p. 108, doi. 10.1007/s11899-009-0015-4
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2009 AND VI 4 AND IP 2
Results: 8
1
2
Clinical implications of c-Kit mutations in acute myelogenous leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2009, v. 4, n. 2, p. 77, doi. 10.1007/s11899-009-0011-8
- By:
- Publication type:
- Article
3
Predicting the response of CML patients to tyrosine kinase inhibitor therapy.
- Published in:
- Current Hematologic Malignancy Reports, 2009, v. 4, n. 2, p. 59, doi. 10.1007/s11899-009-0009-2
- By:
- Publication type:
- Article
4
The role of gemtuzumab ozogamicin in combination chemotherapy regimens for primary resistant or relapsed acute myeloid leukemia.
- Published in:
- 2009
- By:
- Publication type:
- Report
5
Chronic myelogenous leukemia stem cells: What’s new?
- Published in:
- Current Hematologic Malignancy Reports, 2009, v. 4, n. 2, p. 66, doi. 10.1007/s11899-009-0010-9
- By:
- Publication type:
- Article
6
Treatment of immunoglobulin light chain amyloidosis.
- Published in:
- Current Hematologic Malignancy Reports, 2009, v. 4, n. 2, p. 91, doi. 10.1007/s11899-009-0013-6
- By:
- Publication type:
- Article
7
Treatment of relapsed and refractory myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2009, v. 4, n. 2, p. 99, doi. 10.1007/s11899-009-0014-5
- By:
- Publication type:
- Article
8
MicroRNA expression in acute myeloid leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2009, v. 4, n. 2, p. 83, doi. 10.1007/s11899-009-0012-7
- By:
- Publication type:
- Article